NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 50 of 219 results found.

Activity Company Description Location
Company APIE Therapeutics Inc. Activity: Research and Development Research and Development Company Description

APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies.

Location Cary
Company Propella Therapeutics Inc. Activity: Research and Development Research and Development Company Description Propella Therapeutics is a privately held development stage company developing treatments for chronic joint pain due to osteoarthritis and prostate cancer. Its pipeline of patented candidates include Phase-3 ready CGS-200-5, and PRL-02. Location Pittsboro
Company 9 Meters Biopharma Activity: Sales and Operations Sales and Operations Company Description 9 Meters Biopharma in-licenses, develops and commercializes therapeutics for rare and orphan gastrointestinal diseases. Location Raleigh
Company Achelios Therapeutics Inc. Activity: Research and Development Research and Development Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. Location Durham
Company Adrenas Therapeutics Inc. Activity: Research and Development Research and Development Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company Adroit Pharmaceutical Development LLC Activity: Contract Research and Testing Contract Research and Testing Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. Location Durham
Company AegisCN LLC Activity: Research and Development Research and Development Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. Location Durham
Company Aerami Therapeutics Activity: Research and Development Research and Development Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. Location Durham
Company Aestas Pharma Inc. Activity: Research and Development Research and Development Company Description Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. Location Durham
Company Agile Sciences Inc. Activity: Research and Development Research and Development Company Description Agile Sciences is developing small molecules that inhibit bacterial resistance through a novel mode of action that enhances antibiotic activity. Location Raleigh
Company AimMax Therapeutics Inc. Activity: Research and Development Research and Development Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. Location Durham
Company ALG Therapeutics LLC Activity: Research and Development Research and Development Company Description ALG Therapeutics develops pharmaceutical products for pain disorders. Location Chapel Hill
Company AlphaVax Inc. Activity: Research and Development Research and Development Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. Location Research Triangle Park
Company Altavant Sciences Inc. Activity: Research and Development Research and Development Company Description Altavant is a clinical stage biopharmaceutical company developing therapies for rare respiratory diseases. Altavant's therapeutic focus is in pulmonary arterial hypertension (PAH) and bronchiolitis obliterans syndrome (BOS). Location Cary
Company Alterna Therapeutics Inc. Activity: Research and Development Research and Development Company Description Alterna Therapeutics is developing first-in-class small molecules targeting the SHIP enzyme. Alterna is exploring its lead compounds in the areas of obesity, diabetes, bone marrow transplant and post-myeloblative therapy, cancer and Alzheimer's disease. Location Durham
Company Amalgent Therapeutics LLC Activity: Research and Development Research and Development Company Description Amalgent is a clinical-stage company developing oral pain management therapeutics. Location Chapel Hill
Company AMO Pharma Ltd. Activity: Research and Development Research and Development Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. Location Durham
Company Aniluxx Biotechnology Inc. Activity: Research and Development Research and Development Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. Location Chapel Hill
Company ARC Therapeutics LLC Activity: Research and Development Research and Development Company Description ARC Therapeutics is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. Location Research Triangle Park
Company Ardeal Pharma Inc. Activity: Research and Development Research and Development Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. Location Brevard
Company Ardeal Research Institute Activity: Research and Development Research and Development Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. Location Brevard
Company Arrevus Inc. Activity: Research and Development Research and Development Company Description Arrevus is a clinical stage biotechnology company developing novel therapeutics for unmet medical needs in infectious disease and oncology. Location Research Triangle Park
Company Arrivo BioVentures LLC Activity: Research and Development Research and Development Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. Location Morrisville
Company Aruna Bio Activity: Research and Development Research and Development Company Description Aruna Bio develops neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics. Location Raleigh
Company Atox Bio Inc. Activity: Research and Development Research and Development Company Description Atox Bio develops novel immunomodulators to treat critically ill patients. Therapeutic indications include necrotizing soft tissue infections. Location Durham
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Auration Biotech Inc. Activity: Research and Development Research and Development Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. Location Chapel Hill
Company Avicenna Therapeutics Activity: Research and Development Research and Development Company Description Avicenna Therapeutics is developing NOSH-platform eNSAIDs to treat cancer. Location Raleigh
Company Avior Inc. Activity: Research and Development Research and Development Company Description Avior is developing a nanoparticle-based drug delivery technology to deliver lipophilic drugs with high bioavailability. It is testing its technology using a molecule for the treatment of pruritus in chronic kidney disease. Location Durham
Company Avolynt Inc. Activity: Research and Development Research and Development Company Description Avolynt is developing therapeutics for rare and metabolic disease. Avolynt's lead programs target Type 2 diabetes, NASH and Post Bariatric Hypoglycemia. Location Research Triangle Park
Company Balanced pHarma Inc. Activity: Research and Development Research and Development Company Description Balanced pHarma is developing a pH-balanced dental anesthetic drug. Location Cornelius
Company Ballek Biologics LLC Activity: Research and Development Research and Development Company Description Ballek Biologics is developing a therapeutic to reverse opioid overdose. Location Raleigh
Company Banner Life Sciences LLC Activity: Research and Development Research and Development Company Description Banner Life Sciences develops formulation technologies (gelcaps, tablets and sterile injectables) and licenses and markets prescription, over-the-counter and nutritional products. Location High Point
Company Basking Biosciences Inc. Activity: Research and Development Research and Development Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. Location Research Triangle Park
Company Beam Therapeutics Activity: Production and Manufacturing Production and Manufacturing Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. Location Durham
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company Belhaven BioPharma Inc. Activity: Research and Development Research and Development Company Description Belhaven BioPharma is developing a dry powder nasal formulation of epinephrine to treat anaphylaxis. Location Chapel Hill
Company BioAesthetics Corporation Activity: Research and Development Research and Development Company Description BioAesthetics Corporation is developing a nipple areolar complex graft that allows the patients' cells to grow into the graft for use in breast reconstruction. Location Research Triangle Park
Company Biocomposites Inc. Activity: Sales and Operations Sales and Operations Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. Location Wilmington
Company BioKier Inc. Activity: Research and Development Research and Development Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing a novel treatment for diabetes. Location Chapel Hill
Company BioLink Life Sciences Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description BioLink provides contract product development support through custom synthesis and testing for the pharmaceutical, nutraceuticals, animal health and chemical industries. Location Cary
Company BioMarck Pharmaceuticals Ltd. Activity: Research and Development Research and Development Company Description BioMarck develops drugs to treat pulmonary diseases and disorders, such as chronic obstructive pulmonary disease, ARDS, cystic fibrosis and lung cancer. Location Durham
Company Bionpharma Inc. Activity: Sales and Operations Sales and Operations Company Description Bionpharma partners with pharmaceutical companies to in-license, out-license, develop, manufacture and distribute generic and over-the-counter products. Its Raleigh location is a sales office. Location Morrisville
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company Blue Ridge Institute for Medical Research Activity: Research and Development Research and Development Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. Location Horse Shoe
Company BreStem Therapeutics Inc. Activity: Research and Development Research and Development Company Description BreStem Therapeutics is developing a stem cell therapy to treat pulmonary fibrosis. Location Raleigh
Company Brii Biosciences Inc. Activity: Research and Development Research and Development Company Description Brii Biosciences combines partnerships, research and development, and digital and data insight to improve access to medicines for patients in China. Location Durham
Company Bryn Pharma LLC Activity: Research and Development Research and Development Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. Location Raleigh
Company Campbell University Pharmaceutical Education and Research Center Activity: Contract Research and Testing Contract Research and Testing Company Description The Pharmaceutical Education & Research Center (PERC) offers analytical, formulation, R&D, clinical manufacturing and training services to the pharma and biotech industries, compounding pharmacies, government agencies and other academic institutions. Location Buies Creek
Company Cancer Advances Inc. Activity: Research and Development Research and Development Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. Location Durham